abagovomab 39
abciximab 33
abituzumab 27
abrilumab 23
actoxumab 23
adalimumab 17
aducanumab 15
afasevikumab 19
alacizumab_pegol 12
alemtuzumab 35
alirocumab 25
amatuximab 49
andecaliximab 27
anifrolumab 25
anrukinzumab 17
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 19
ascrinvacumab 11
atezolizumab 16
atinumab 20
avelumab 19
basiliximab 41
bavituximab 40
begelomab 33
benralizumab 33
bevacizumab_beta 23
bezlotoxumab 23
bimagrumab 22
bleselumab 26
blinatumomab 39
blosozumab 31
bococizumab 20
brazikumab 20
brentuximab_vedotin 41
briakinumab 21
brodalumab 17
brolucizumab 29
brontictuzumab 31
burosumab 22
cabiralizumab 31
camrelizumab 15
canakinumab 24
cantuzumab_ravtansin 45
carlumab 19
carotuximab 24
cergutuzumab_amunaleukin2 29
cergutuzumab_amunaleukin 29
certolizumab_pegol 27
cetiximab 44
citatuzumab_bogatox 28
cixutumumab 36
clivatuzumab_tetraxetan 22
codrituzumab 32
conatumumab 20
concizumab 32
crenezumab 23
crizanlizumab 29
crotedumab 23
dacetuzumab 24
daclizumab 18
dalotuzumab 32
dapirolizumab_pegol 27
daratumumab 16
dectrekumab 11
demcizumab 29
denosumab 9
depatuxizumab 26
depatuxizumab_mafodotin 26
dezamizumab 24
dinutuximab 39
diridavumab 24
domagrozumab 19
drozitumab 25
duligotuzumab 20
durvalumab 16
dusigitumab 26
efalizumab 37
efungumab 31
eldelumab 21
elezanumab 26
elgemtumab 14
elotuzumab 19
emactuzumab 25
emapalumab 32
emibetuzumab 23
enavatuzumab 26
enfortumab_vedotin 16
enoblituzumab 20
enokizumab 26
enoticumab 23
ensituximab 41
eptinezumab 18
erenumab 28
etaracizumab 18
etrolizumab 23
evinacumab 24
evolocumab 27
farletuzumab 6
fasinumab 30
fezakinumab 25
fibatuzumab 14
ficlatuzumab 25
firivumab 35
flanvotumab 24
fletikumab 33
foralumab 17
foravirumab 18
fremanezumab 35
fresolimumab 19
fulranumab 22
futuximab 25
galcanezumab 20
ganitumab 25
gantenerumab 15
gemetuzumab 37
gemtuzumab2 32
gemtuzumab 30
gevokizumab 27
girentuximab 31
glembatumumab 22
glembatumumab_vedotin 22
guselkumab 22
ibalizumab 33
ibritumomab 37
icrucumab 15
idarucizumab 36
ifabotuzumab 14
imalumab 18
imgatuzumab 24
inclacumab 25
indatuximab_ravtansin 34
indusatumab 22
inebilizumab 26
intetumumab 19
iodine_girentuximab 31
ipilimumab 11
iratumumab 20
isatuximab 38
itolizumab 26
ixekizumab 36
labetuzumab_govitecan 27
lambrolizumab 34
lampalizumab 27
lanadelumab 19
landogrozumab 20
laprituximab 32
lebrikizumab 37
lendalizumab 27
lenzilumab 24
lifastuzumab_vedotin 25
ligelizumab 24
lilotomab 42
lirilumab 30
lodelcizumab 21
lokivetmab 27
lorvotuzumab_mertansin 24
lucatumumab 33
lumretuzumab 22
lupartumab 20
lutikizumab 19
margetuximab 35
milatuzumab 43
mirvetuximab 39
mirvetuximab_soravtansin 39
modotuximab 47
mogamulizumab 29
monalizumab 28
motavizumab 35
moxetumomab_pasudotox 26
namilumab 27
naratuximab 35
naratuximab_emtansin 35
narnatumab 22
navicixizumab2 28
navicixizumab 31
navivumab 38
necitumumab 14
nemolizumab 27
nesvacumab 17
nivolumab 18
obiltoxaximab 24
obinutuzumab 32
ocaratuzumab 25
ofatumumab 21
olaratumab 25
olokizumab 24
omalizumab 22
onartuzumab 25
ontuxizumab 36
opicinumab 15
orticumab 14
otelixizumab 40
oxelumab 14
ozanezumab 34
pamrevlumab 14
panobacumab 25
parsatuzumab 32
pasotuxizumab 22
pateclizumab 19
patritumab 22
pembrolizumab 34
perakizumab 25
pidilizumab 22
pinatuzumab_vedotin 19
plozalizumab 27
pogalizumab 28
polatuzumab_vedotin 22
ponezumab 37
prezalumab 17
pritoxaximab 43
quilizumab 21
racotumomab 35
radretumab 19
ralpancizumab 25
ramucirumab 15
ranevetmab 33
ranibizumab 23
refanezumab 26
remtolumab 20
rilotumumab 18
rinucumab 20
risankizumab 32
rituximab 26
rivabazumab 25
robatumumab 21
roledumab 33
romosozumab 25
rontalizumab 26
rosmantuzumab 23
rozanolixizumab 24
sacituzumab 32
sacituzumab_govitecan 32
samalizumab 31
sapelizumab 24
sarilumab 18
secukinumab 19
seribantumab 20
setoxaximab 46
sifalimumab 17
siltuximab 22
simtuzumab 31
sirukumab 15
solanezumab 29
solitomab 32
stamulumab 23
suptavumab 27
suvizumab 21
tabalumab 25
tadocizumab 21
tamtuvetmab 36
tanezumab 27
tarextumab 13
tavolixizumab 13
telisotuzumab 32
teplizumab 25
tesidolumab 29
tezepelumab 34
tigatuzumab 17
tildrakizumab 25
timolumab 18
tisotumab 11
tosatoxumab 37
tositumomab 34
tralokinumab 39
trastuzumab 24
tregalizumab 22
trevogrumab 12
ublituximab 35
urelumab 22
ustekinumab 31
utomilumab 34
vadastuximab 30
vadastuximab_talirin 30
vandortuzumab_vedotin 23
vantictumab 28
vanucizumab2 23
vanucizumab 39
varlilumab 19
vatelizumab 25
vedolizumab 32
veltuzumab 21
vesencumab 11
vorsetuzumab 25
vorsetuzumab_mafodotin 25
vunakizumab 36
xentuzumab 20
zatuximab 47
